CS logo
small CS logo
Pennsylvania Hospital

Philadelphia, Pennsylvania, United States
Teaching hospital in Philadelphia, Pennsylvania
800 Spruce St, Philadelphia, PA 19107
515 Beds

About Pennsylvania Hospital


Pennsylvania Hospital is a private, non-profit, 515-bed teaching hospital located in Center City Philadelphia and is part of the University of Pennsylvania Health System.
There are 515 beds in Pennsylvania Hospital.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
33
University of Pennsylvania
22
Gynecologic Oncology Group
15
Alliance for Clinical Trials in Oncology
3
ECOG-ACRIN Cancer Research Group
3
GOG Foundation
3
Abbott Medical Devices
2
Boston Scientific Corporation
2
Children's Hospital of Philadelphia
2
MedImmune LLC
2
NSABP Foundation Inc
2
Total Rows: 51

Clinical Trials at Pennsylvania Hospital


During the past decade, Pennsylvania Hospital conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 50 clinical trials were completed, i.e. on average, 151.5% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 20 clinical trials were completed. i.e. 181.8% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years5555553344773311445555121244887744Started TrialsCompleted Trails20152016201720182019202020212022051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer
1992-05-01
Completed
Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer
1994-03-01
2004-08-01
Completed
25
Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer
1996-03-01
Completed
324
Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus
1997-08-01
Terminated
30
Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus
1997-08-01
Terminated
Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix
1997-10-01
Completed
870
Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer
1998-08-01
Terminated
45
Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer
1998-05-01
Terminated

Rows per page:

1–100 of 132

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Pennsylvania Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 33 trials, followed by "University of Pennsylvania" with 22 trials sponsored, "Gynecologic Oncology Group" with 15 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored. Other sponsors include 51 different institutions and companies that sponsored additional 51 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Pennsylvania Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 28 trials as a collaborator, "NRG Oncology" with 11 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator and "Medical University of South Carolina" with 3 trials as a collaborator. Other collaborators include 141 different institutions and companies that were collaborators in the rest 128 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 33National CancerInstitute (NCI): 33University of Pennsylvania: 22University of Pennsylvania: 22Gynecologic OncologyGroup: 15Gynecologic OncologyGroup: 15Alliance for ClinicalTrials in Oncology: 3Alliance for ClinicalTrials in Oncology: 3ECOG-ACRIN CancerResearch Group: 3ECOG-ACRIN CancerResearch Group: 3GOG Foundation: 3GOG Foundation: 3Abbott Medical Devices: 2Abbott Medical Devices: 2Boston Scientific Corporation: 2Boston Scientific Corporation: 2Children's Hospital ofPhiladelphia: 2Children's Hospital ofPhiladelphia: 2MedImmune LLC: 2MedImmune LLC: 2

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 28National CancerInstitute (NCI): 28NRG Oncology: 11NRG Oncology: 11Cancer and LeukemiaGroup B: 4Cancer and LeukemiaGroup B: 4National Heart, Lung,and Blood Institute(NHLBI): 4National Heart, Lung,and Blood Institute(NHLBI): 4Medical University ofSouth Carolina: 3Medical University ofSouth Carolina: 3NCIC Clinical Trials Group: 3NCIC Clinical Trials Group: 3North Central CancerTreatment Group: 3North Central CancerTreatment Group: 3SWOG Cancer ResearchNetwork: 3SWOG Cancer ResearchNetwork: 3University of Pennsylvania: 3University of Pennsylvania: 3University of Pittsburgh: 3University of Pittsburgh: 3

Clinical Trials Conditions at Pennsylvania Hospital


According to Clinical.Site data, the most researched conditions in "Pennsylvania Hospital" are "Fallopian Tube Endometrioid Adenocarcinoma" (7 trials), "Ovarian Cancer" (7 trials), "Ovarian Endometrioid Adenocarcinoma" (7 trials), "Fallopian Tube Clear Cell Adenocarcinoma" (6 trials) and "Fallopian Tube Mucinous Adenocarcinoma" (6 trials). Many other conditions were trialed in "Pennsylvania Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Pennsylvania Hospital


Most popular intervention types in "Pennsylvania Hospital" are "Drug" (78 trials), "Other" (55 trials), "Biological" (30 trials), "Procedure" (16 trials) and "Device" (15 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (28 trials), "Quality-of-Life Assessment" (17 trials), "Paclitaxel" (16 trials), "Bevacizumab" (12 trials) and "Carboplatin" (12 trials). Other intervention names were less common.

Clinical Trials Genders at Pennsylvania Hospital


The vast majority of trials in "Pennsylvania Hospital" are 86 trials for "All" genders and 46 trials for "Female" genders.

Clinical Trials Status at Pennsylvania Hospital


Currently, there are NaN active trials in "Pennsylvania Hospital". undefined are not yet recruiting, 12 are recruiting, 28 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 71 completed trials in Pennsylvania Hospital, undefined suspended trials, and 12 terminated clinical trials to date.
Out of the total trials that were conducted in Pennsylvania Hospital, 10 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 60 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 26 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 60Phase 3: 60Not Applicable: 26Not Applicable: 26Phase 2: 24Phase 2: 24Phase 1: 10Phase 1: 10Phase 4: 3Phase 4: 3

Created with Highcharts 11.1.0Trials StatusCompleted: 71Completed: 71Active, not recruiting: 28Active, not recruiting: 28Recruiting: 12Recruiting: 12Terminated: 12Terminated: 12Unknown status: 5Unknown status: 5Withdrawn: 3Withdrawn: 3Enrolling by invitation: 1Enrolling by invitation: 1

Departments of Pennsylvania Hospital


Pennsylvania Hospital has several departments that took part in Clinical trials: "Abramson Cancer Center at Pennsylvania Hospital" - 8 trials
Departments List
Total Rows: 1